Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

SHUSTERMAN, Suzanne ; LONDON, Wendy B ; GAN, Jacek ; EICKHOFF, Jens ; DESANTES, Kenneth B ; COHN, Susan L ; HECHT, Toby ; GADBAW, Brian ; REISFELD, Ralph A ; MARIS, John M ; SONDEL, Paul M ; GILLIES, Stephen D ; HANK, Jacquelyn A ; VOSS, Stephan D ; SEEGER, Robert C ; REYNOLDS, C. Patrick ; KIMBALL, Jennifer ; ALBERTINI, Mark R ; WAGNER, Barrett

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Tarhini, Ahmad A ; Lee, Sandra J ; Hodi, F Stephen ; Rao, Uma N M ; Cohen, Gary I ; Hamid, Omid ; Hutchins, Laura F ; Sosman, Jeffrey A ; Kluger, Harriett M ; Eroglu, Zeynep ; Koon, Henry B ; Lawrence, Donald P ; Kendra, Kari L ; Minor, David R ; Lee, Carrie B ; Albertini, Mark R ; Flaherty, Lawrence E ; Petrella, Teresa M ; Streicher, Howard ; Sondak, Vernon K ; Kirkwood, John M

United States: American Society of Clinical Oncology

Texto completo disponível

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)

Agarwala, Sanjiv S ; Lee, Sandra J ; Yip, Waiki ; Rao, Uma N ; Tarhini, Ahmad A ; Cohen, Gary I ; Reintgen, Douglas S ; Evans, Terry L ; Brell, Joanna M ; Albertini, Mark R ; Atkins, Michael B ; Dakhil, Shaker R ; Conry, Robert M ; Sosman, Jeffrey A ; Flaherty, Lawrence E ; Sondak, Vernon K ; Carson, William E ; Smylie, Michael G ; Pappo, Alberto S ; Kefford, Richard F ; Kirkwood, John M

United States: American Society of Clinical Oncology

Texto completo disponível

Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from the peripheral blood of a melanoma patient following successful treatment with immune checkpoint blockade

Albertini, Mark R. ; Zuleger, Cindy L ; Newton, Michael A ; Ma, Xiuyu ; Ong, Irene M

Texto completo disponível

Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma

Albertini, Mark R. ; Morris, Zachary Scott ; Hank, Jacquelyn A ; Ranheim, Erik ; Zuleger, Cindy L ; McDowell, Kimberly ; Quale, Renae M ; Monson, Molly ; Clements, Erin ; Koehn, Tamara ; Neuman, Heather B. ; Weber, Sharon M. ; Racz, Jennifer ; Henry, Mary Beth ; Reinstad, Emily ; Kim, KyungMann ; Gillies, Stephen D. ; Sondel, Paul M.

Texto completo disponível

United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma

Tarhini, Ahmad A. ; Lee, Sandra J. ; Hodi, F. Stephen ; Rao, Uma N. M. ; Cohen, Gary Irvin ; Hamid, Omid ; Hutchins, Laura Fulper ; Sosman, Jeffrey Alan ; Kluger, Harriet M. ; Sondak, Vernon K. ; Koon, Henry B. ; Lawrence, Donald P. ; Kendra, Kari Lynn ; Minor, David R. ; Lee, Carrie B. ; Albertini, Mark R. ; Flaherty, Lawrence E. ; Petrella, Teresa M. ; Kirkwood, John M.

Texto completo disponível

A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611)

Tarhini, Ahmad A. ; Lee, Sandra J. ; Rao, Uma N. M. ; Nagarajan, Arun ; Albertini, Mark R. ; Mitchell, Jerry W ; Wong, Stuart J. ; Taylor, Mark A. ; Laudi, Noel ; Truong, Phu Van ; Conry, Robert Martin ; Kirkwood, John M.

Texto completo disponível

A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk melanoma (U.S. Intergroup E1609): Preliminary safety and efficacy of the ipilimumab arms

Tarhini, Ahmad A. ; Lee, Sandra J. ; Hodi, F. Stephen ; Rao, Uma N. M. ; Cohen, Gary I ; Hamid, Omid ; Hutchins, Laura Fulper ; Sosman, Jeffrey Alan ; Kluger, Harriet M. ; Sondak, Vernon K. ; Koon, Henry B. ; Lawrence, Donald P. ; Kendra, Kari Lynn ; Minor, David R. ; Lee, Carrie B. ; Albertini, Mark R ; Flaherty, Lawrence E. ; Petrella, Teresa M. ; Kirkwood, John M.

Texto completo disponível

A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand

Bhardwaj, Nina ; Pavlick, Anna C. ; Ernstoff, Marc S. ; Hanks, Brent Allen ; Albertini, Mark R. ; Luke, Jason John ; Yellin, Michael Jay ; Keler, Tibor ; Davis, Thomas A. ; Crocker, Andrea ; Vitale, Laura ; Morishima, Chihiro ; Friedlander, Philip Adam ; Cheever, Martin A. ; Fling, Steven

Texto completo disponível

Phase I study to evaluate toxicity and feasibility of intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma

Albertini, Mark R. ; Ranheim, Erik ; Zuleger, Cindy ; Sondel, Paul M. ; Hank, Jacquelyn A ; Bridges, Alan ; Newton, Michael ; McFarland, Thomas ; Collins, Jennifer ; Clements, Erin ; Henry, MaryBeth ; Neuman, Heather B. ; Weber, Sharon M. ; Whalen, Giles Francis ; Galili, Uri

Texto completo disponível